Karen Willard-Gallo

16PUBLICATIONS
94CO-AUTHORS
Radiation therapyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 06, 2026
Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy.

Christelle Bouchart, Oier Azurmendi Senar, Julie Navez

|Nov 26, 2025
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.

Andreas Papagiannis, Samira Majjaj, Francois P Duhoux

|Aug 29, 2024
Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer.

Noémie Thomas, Soizic Garaud, Mireille Langouo

|Sep 08, 2023
Concomitant Expression of CD39, CD69, and CD103 Identifies Antitumor CD8+ T Cells in Breast Cancer Implications for Adoptive Cell Therapy.

Grace Ivonne Gattas Lama, Gregory Noél, Francisco Carlos López Márquez

|Jul 22, 2022
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis.

Diogo Martins-Branco, Guilherme Nader-Marta, Ana Tecic Vuger

|Feb 25, 2022
A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma.

Karim Gourari, Julien Catherine, Soizic Garaud

Pageof 3

Frequent Collaborators

3 joint publications

Christos Sotiriou

2 joint publications

Laurence Buisseret

2 joint publications

Evelyne Collignon

2 joint publications

Ahmad Awada